All 1 Debates between Beccy Cooper and Chris Elmore

Oral Answers to Questions

Debate between Beccy Cooper and Chris Elmore
Tuesday 16th June 2026

(1 month, 2 weeks ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Chris Elmore Portrait The Parliamentary Under-Secretary of State for Foreign, Commonwealth and Development Affairs (Chris Elmore)
- View Speech - Hansard - - - Excerpts

The UK has allocated £26.9 million of UK aid funding to support the response to the current Ebola outbreak within the DRC. That funding will strengthen disease surveillance and rapid response, and improve infection prevention and control. We are also working with the World Health Organisation and the Africa Centres for Disease Control and Prevention to help scale up the response and adapt existing programmes. This is a deeply concerning situation. Over the coming weeks, we will continue to work intensively alongside international partners to monitor developments and take the necessary action to protect both regional and global health security.

Beccy Cooper Portrait Dr Cooper
- View Speech - Hansard - -

The Ebola outbreak now spans 29 health zones across three eastern provinces and is a reminder to us all that infectious diseases do not respect borders. With global health funding under significant pressure, does the Minister share my concern that we risk undermining the early warning systems that ultimately protect people here at home? Can he set out what steps the UK is taking to maintain its leadership role in global security?

Chris Elmore Portrait Chris Elmore
- View Speech - Hansard - - - Excerpts

I am glad to say that the UK is not stepping back; our response to the outbreak confirms that. We currently sit on the board of the WHO, the Global Fund, Gavi and the Pandemic Fund. Our investment helps to maintain critical global health security infrastructure, as well as tackling other health security threats such as antimicrobial resistance. Our leadership is amplified by world-class research and development, and is a trailblazer in the life sciences sector.